InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,950.89
(
-0.58%
)
US TECH 100
20,349.20
(
-0.69%
)
Dow Jones
43,749.67
(
-0.47%
)
Brent Oil
72.29
(
0.58%
)
Bitcoin
88,133.51
(
-2.68%
)
Post# of 253597
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 86124

Wednesday, 11/11/2009 12:55:00 PM

Wednesday, November 11, 2009 12:55:00 PM

Post# of 253597

[After each report, Merck said doctors shouldn’t change treatment based on the results and urged them to wait for data from a larger trial to be completed in 2012.

This larger one is the IMPROVE-IT trial (Vytorin vs. Simvastatin) and should Zetia disappoint in ARBITER 6, outcome for Vytorin in the IMPROVE-IT trial looks shady.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up